Seeking to address this gap, the objectives of this study were to investigate how a range of concentrations of mifepristone affected the migration and proliferation of oral cancer cells, the underlying PI3K-Akt and MAPK signalling pathways, and EMT markers (E-Cadherin and N-Cadherin) in oral cancer cells. This evidence concerns the gene CDH2 and lip and oral cavity carcinoma.